Brief: Aim Immunotech Announces Extension Of Subscription Period
25/02/2026 14:02
Feb 25 (Reuters) - AIM ImmunoTech Inc AIM.A: AIM IMMUNOTECH ANNOUNCES EXTENSION OF SUBSCRIPTION PERIOD OF ITS PREVIOUSLY ANNOUNCED RIGHTS OFFERING TO MARCH 3, 2026 Source text: ID:nGNX94cyB0 Further company coverage: AIM.A (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential